Chen Renbiao, Zhao Yonglei, Umba Mabombo Pierre, Hu Hongjie, Zhou Xiaoxuan
Department of Radiology, Sir Run-Run Shaw Hospital, Zhejiang University, Hangzhou, People's Republic of China.
J Hepatocell Carcinoma. 2022 Oct 26;9:1105-1108. doi: 10.2147/JHC.S376660. eCollection 2022.
Radiofrequency ablation (RFA) has become one of the commonly used treatment methods for hepatocellular carcinoma (HCC). It is widely available in the clinic and presents the advantages of short recovery time and a less invasive approach. Only a few complications, such as hemorrhage, ascites, and duct injury, have been reported after RFA for HCC. Herein, we report for the first time the case of a patient diagnosed with recurrent HCC in whom thrombotic thrombocytopenic purpura (TTP) was diagnosed as a complication of the RFA procedure. A 64-year-old male patient with a 2-year history of resected-stage V HCC, in whom later recurrence occurred, underwent RFA for HCC. This patient had a rapid drop in platelets and some petechiae on the wrists after RFA. Combining the clinical and laboratory tests, the diagnosis of TTP was reached. We immediately used plasmapheresis combined with drug therapy, which successfully treated the clinical condition of TTP, with no evidence of recurrence or other complications 1 year after initial treatment. TTP is a rare complication of RFA procedures. Prompt diagnosis and aggressive treatment measures are critical. Through this case report, we hope to raise awareness of the complications of RFA.
射频消融术(RFA)已成为肝细胞癌(HCC)常用的治疗方法之一。它在临床上广泛应用,具有恢复时间短和侵入性较小的优点。肝癌射频消融术后仅报道了少数并发症,如出血、腹水和胆管损伤。在此,我们首次报告一例诊断为复发性肝癌的患者,其血栓性血小板减少性紫癜(TTP)被诊断为射频消融术的并发症。一名64岁男性患者,有2年的V期肝癌切除病史,后来复发,接受了肝癌射频消融术。该患者在射频消融术后血小板迅速下降,手腕出现一些瘀点。结合临床和实验室检查,确诊为TTP。我们立即采用血浆置换联合药物治疗,成功治疗了TTP的临床症状,初始治疗1年后无复发或其他并发症迹象。TTP是射频消融术的一种罕见并发症。及时诊断和积极的治疗措施至关重要。通过本病例报告,我们希望提高对射频消融术并发症的认识。